AKAM vs ORMP
Akamai Technologies Inc (AKAM) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
AKAM does not have a complete income-statement cache yet.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the AKAM and ORMP stock pages for the full models.
Not investment advice.